Cordis Corporation Announces Two-Year Results From The STROLL Trial

Trial Assesses the Safety and Efficacy of the S.M.A.R.T.� Vascular Stent Systems in the Superficial Femoral Artery Cordis Corporation today announced the presentation of the two-year STROLL study results at the Abstracts and Late Breaking Clinical Trials session at ISET 2013.�?�? �? William A. Gray, MD, Director of Endovascular Services, Cardiovascular Research Foundation, New York, presented the results of the STROLL study (S.M.A.R.T.� Vascular Stent Systems in the TReatment of Obstructive SuperficiaL FemoraL Artery Disease) on behalf of the study investigators...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/74SGl5Q0TG8/255295.php

sport sport medical sport news